These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 4556774

  • 21. Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification.
    Eshhar Z, Gafni M, Givol D, Sela M.
    Eur J Immunol; 1971 Nov; 1(5):323-9. PubMed ID: 4945634
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Heart transplantation in congenic strains of mice.
    Corry RJ, Winn HJ, Russell PS.
    Transplant Proc; 1973 Mar; 5(1):733-5. PubMed ID: 4572133
    [No Abstract] [Full Text] [Related]

  • 32. Blastic reaction of the regional lymph node as a method for quantitative evaluation of tissue incompatibility.
    Ostrowski K, Zaleski M, Rymaszewska-Kossakowska T.
    Arch Immunol Ther Exp (Warsz); 1969 Mar; 17(3):342-55. PubMed ID: 4895933
    [No Abstract] [Full Text] [Related]

  • 33. Blastic reaction of the regional lymph node as a method for quantitative evaluation of tissue incompatibiliy.
    Ostrowski K, Zaleski M, Rymaszewska-Kossakowska.
    Arch Immunol Ther Exp (Warsz); 1969 Mar; 17(3):342-55. PubMed ID: 4898276
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Contribution of CD4+ cells to allorejection across a class I major histocompatibility complex barrier in congeneic rats.
    Stepkowski SM, Goto S, Wiggins J, Christopher J, Kahan BD.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):172-3. PubMed ID: 1990506
    [No Abstract] [Full Text] [Related]

  • 40. Suppression of specific MLC responsiveness during skin allograft rejection in rats.
    Wonigeit K, Pichlmayr R.
    Transplant Proc; 1977 Mar; 9(1):765-70. PubMed ID: 68602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.